Letter to the Editor Reply
Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?”
Ferhat Dindaş 1
, Hüseyin Güngör 2
, Mehmet Ekici 3
, Pınar Akokay 4
, Füsun Erhan 5
, Mustafa Doğduş 1
, Mehmet Birhan Yılmaz 6
, Hüseyin Güngör 2
, Mehmet Ekici 3
, Pınar Akokay 4
, Füsun Erhan 5
, Mustafa Doğduş 1
, Mehmet Birhan Yılmaz 6
1Department of Cardiology, Faculty of Medicine, Uşak Training and Research Hospital, Uşak, Turkey
2Department of Pharmacology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey
3Department of Physiology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey
4Department of Histology, İzmir Kavram Vocational School, İzmir, Turkey
5Department of Histology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey
6Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey
2Department of Pharmacology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey
3Department of Physiology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey
4Department of Histology, İzmir Kavram Vocational School, İzmir, Turkey
5Department of Histology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey
6Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey
Anatol J Cardiol 2022; 26(4): 344-344 DOI: 10.5152/AnatolJCardiol.2021.1371